American Journal of Respiratory and Critical Care Medicine Vol 166. pp. 1332-1337, (2002)
© 2002 American Thoracic Society
A Role for Vascular Endothelial Growth Factor in Acute and Resolving Lung Injury
David R. Thickett,
Lynne Armstrong and
Ann B. Millar
Lung Research Group, University of Bristol Medical School Unit, Southmead Hospital, Bristol, United Kingdom
Correspondence and requests for reprints should be addressed to A. B. Millar, M.D., Lung Research Group, University of Bristol Medical School Unit, Southmead Hospital, Westbury on Trym, Bristol BS10 5NB, UK. E-mail: Ann.Millar{at}bristol.ac.uk
We have previously reported, in patients with acute respiratory distress syndrome (ARDS), elevated plasma levels of vascular endothelial growth factor (VEGF) that became reduced in those who recovered. To examine the potential effect of VEGF on the epithelial side of the alveolarcapillary membrane, we compared VEGF levels in the epithelial lining fluid (ELF) of the same 40 patients with ARDS, and in 28 patients at risk of ARDS. We measured intrapulmonary VEGF levels in 23 patients on Days 1 and 4 after admission to the intensive therapy unit and related these levels to recovery. ELF from subjects with ARDS contained lower levels of VEGF than did ELF from at-risk subjects (1,076 and 7,674 pg/ml, respectively, p = 0.0004) and increased ELF levels at Day 4 were associated with recovery (p = 0.001). Alveolar macrophages from subjects with ARDS produced significantly less VEGF than those from at-risk subjects (6.3 and 13.0 pg/ml, respectively, p = 0.005). Similarly, alveolar neutrophils from subjects with ARDS produced significantly less VEGF than those at risk (13.9 and 31.5 pg/ml, respectively, p = 0.03). ELF VEGF levels inversely correlated with Lung Injury Score (p = 0.003). These studies suggest that VEGF in the alveolar space may reflect the development of, and recovery from, acute lung injury in a manner opposite to that in plasma.
Key Words: acute respiratory distress syndrome epithelial lining fluid vascular endothelial growth factor
This article has been cited by other articles:

|
 |

|
 |
 
A. A. Nemec and A. Barchowsky
Signal Transducer and Activator of Transcription 1 (STAT1) is Essential for Chromium Silencing of Gene Induction in Human Airway Epithelial Cells
Toxicol. Sci.,
July 1, 2009;
110(1):
212 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Levitt, M. K. Gould, L. B. Ware, and M. A. Matthay
Analytic Review: The Pathogenetic and Prognostic Value of Biologic Markers in Acute Lung Injury
J Intensive Care Med,
May 1, 2009;
24(3):
151 - 167.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gao and K. C. Barnes
Recent advances in genetic predisposition to clinical acute lung injury
Am J Physiol Lung Cell Mol Physiol,
May 1, 2009;
296(5):
L713 - L725.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Hao, L. Wang, and H. Tang
Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells
Am J Physiol Cell Physiol,
April 1, 2009;
296(4):
C821 - C827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A G Richter, S McKeown, S Rathinam, L Harper, P Rajesh, D F McAuley, R Heljasvaara, and D R Thickett
Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis
Thorax,
February 1, 2009;
64(2):
156 - 161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. McKeown, A. G. Richter, C. O'Kane, D. F. McAuley, and D. R. Thickett
MMP expression and abnormal lung permeability are important determinants of outcome in IPF
Eur. Respir. J.,
January 1, 2009;
33(1):
77 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Karlsson, V. Pettila, J. Tenhunen, V. Lund, S. Hovilehto, E. Ruokonen, and For the Finnsepsis Study Group
Vascular Endothelial Growth Factor in Severe Sepsis and Septic Shock
Anesth. Analg.,
June 1, 2008;
106(6):
1820 - 1826.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G D Perkins, F Gao, and D R Thickett
In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury
Thorax,
March 1, 2008;
63(3):
215 - 220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Siner, G. Jiang, Z. I. Cohen, P. Shan, X. Zhang, C. G. Lee, J. A. Elias, and P. J. Lee
VEGF-induced heme oxygenase-1 confers cytoprotection from lethal hyperoxia in vivo
FASEB J,
May 1, 2007;
21(7):
1422 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. F. Voelkel, I. S. Douglas, and M. Nicolls
Angiogenesis in Chronic Lung Disease
Chest,
March 1, 2007;
131(3):
874 - 879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Kunig, V. Balasubramaniam, N. E. Markham, G. Seedorf, J. Gien, and S. H. Abman
Recombinant human VEGF treatment transiently increases lung edema but enhances lung structure after neonatal hyperoxia
Am J Physiol Lung Cell Mol Physiol,
November 1, 2006;
291(5):
L1068 - L1078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Mirzapoiazova, I. Kolosova, P. V. Usatyuk, V. Natarajan, and A. D. Verin
Diverse effects of vascular endothelial growth factor on human pulmonary endothelial barrier and migration
Am J Physiol Lung Cell Mol Physiol,
October 1, 2006;
291(4):
L718 - L724.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A R L Medford and A B Millar
Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?
Thorax,
July 1, 2006;
61(7):
621 - 626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Carpenter, S. Schomberg, and K. R. Stenmark
Endothelin-mediated increases in lung VEGF content promote vascular leak in young rats exposed to viral infection and hypoxia
Am J Physiol Lung Cell Mol Physiol,
December 1, 2005;
289(6):
L1075 - L1082.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kanazawa and J. Yoshikawa
Elevated Oxidative Stress and Reciprocal Reduction of Vascular Endothelial Growth Factor Levels With Severity of COPD
Chest,
November 1, 2005;
128(5):
3191 - 3197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Kunig, V. Balasubramaniam, N. E. Markham, D. Morgan, G. Montgomery, T. R. Grover, and S. H. Abman
Recombinant human VEGF treatment enhances alveolarization after hyperoxic lung injury in neonatal rats
Am J Physiol Lung Cell Mol Physiol,
October 1, 2005;
289(4):
L529 - L535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Hamada, K. Kuwano, M. Yamada, N. Hagimoto, K. Hiasa, K. Egashira, N. Nakashima, T. Maeyama, M. Yoshimi, and Y. Nakanishi
Anti-Vascular Endothelial Growth Factor Gene Therapy Attenuates Lung Injury and Fibrosis in Mice
J. Immunol.,
July 15, 2005;
175(2):
1224 - 1231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Ware, R. J. Kaner, R. G. Crystal, R. Schane, N. N. Trivedi, D. McAuley, and M. A. Matthay
VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema
Eur. Respir. J.,
July 1, 2005;
26(1):
101 - 105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A R L Medford, L J Keen, J L Bidwell, and A B Millar
Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome
Thorax,
March 1, 2005;
60(3):
244 - 248.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G D Perkins, J Roberts, D F McAuley, L Armstrong, A Millar, F Gao, and D R Thickett
Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury
Thorax,
February 1, 2005;
60(2):
153 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A G Richter, E O Maughan, G D Perkins, N Nathani, and D R Thickett
VEGF levels in pulmonary fibrosis
Thorax,
February 1, 2005;
60(2):
171 - 171.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Abadie, F. Bregeon, L. Papazian, F. Lange, B. Chailley-Heu, P. Thomas, P. Duvaldestin, S. Adnot, B. Maitre, and C. Delclaux
Decreased VEGF concentration in lung tissue and vascular injury during ARDS
Eur. Respir. J.,
January 1, 2005;
25(1):
139 - 146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mura, C. C. dos Santos, D. Stewart, and M. Liu
Vascular endothelial growth factor and related molecules in acute lung injury
J Appl Physiol,
November 1, 2004;
97(5):
1605 - 1617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tang, H. B. Rossiter, P. D. Wagner, and E. C. Breen
Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice
J Appl Physiol,
October 1, 2004;
97(4):
1559 - 1566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Lambert, R. Michel, G.-M. Mazmanian, E. M. Dulmet, A. Capderou, P. Herve, C. Planche, and A. Serraf
Induction of pulmonary angiogenesis by adenoviral-mediated gene transfer of vascular endothelial growth factor
Ann. Thorac. Surg.,
February 1, 2004;
77(2):
458 - 463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-I. Choi, D. A. Quinn, K. M. Park, R. K. Moufarrej, B. Jafari, O. Syrkina, J. V. Bonventre, and C. A. Hales
Systemic Microvascular Leak in an In Vivo Rat Model of Ventilator-induced Lung Injury
Am. J. Respir. Crit. Care Med.,
June 15, 2003;
167(12):
1627 - 1632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Tobin
Critical Care Medicine in AJRCCM 2002
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
294 - 305.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 American Thoracic Society
|
|
|